Rocket PharmaceuticalsRCKT

那斯達克 · USD
3.86
+0.07
(+1.85%)
收盤 09/05 04:00 (UTC+8)
09/05 04:00 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
46,92248,51143,96352,24771,14964,38862,694-73,71267,375
研發費用
29,49731,45429,34734,06842,65835,94237,35742,31546,34545,227
推銷及管理費用
17,42517,05714,68418,35125,02028,44625,33727,10927,36722,148
非經常性項目費用
---68-1723,471-----
其他營業費用
----------
營業利益
-46,922
-48,511
-43,963
-52,247
-71,149
-64,388
-62,694
-69,424
-73,712
-67,375
其他收入及費用
179,2301,3901,8982,3882,7033,5262,8403,1764,5375,792
利息費用
473473473473473472473471471471
稅前純益
131,835
-47,594
-42,538
-50,332
-68,919
-61,334
-60,327
-66,719
-69,646
-62,054
所得稅
8,621---------
稅後純益
123,214
-47,594
-42,538
-50,332
-68,919
-61,334
-60,327
-66,719
-69,646
-62,054
基本每股稅後盈餘(元)
1.09-0.42-0.38-0.45-0.62-0.56-0.62-0.71-0.74-0.66
稀釋每股稅後盈餘(元)
1.08-0.42-0.38-0.45-0.62-0.56-0.62-0.71-0.74-0.66
基本平均股數(千股)
112844.00112134.00111787.00111571.00111019.00110093.0097530.0094158.0093746.0093549.00
稀釋平均股數(千股)
114513.00112134.00111787.00111571.00111019.00110093.0097530.0094158.0093746.0093549.00
還原基本每股稅後盈餘(元)
1.09-0.42-0.38-0.45-0.62-0.56-0.62-0.71-0.74-0.66
還原稀釋每股稅後盈餘(元)
1.08-0.42-0.38-0.45-0.62-0.56-0.62-0.71-0.74-0.66
還原基本平均股數(千股)
112,844112,134111,787111,571111,019110,09397,53094,15893,74693,549
還原稀釋平均股數(千股)
114,513112,134111,787111,571111,019110,09397,53094,15893,74693,549
EBITDA(千元)
133,768-45,995-40,936-48,218-68,079-59,948-58,716-65,708-69,046-62,083

大家都在看

HOT